Integrin receptor seeking bio-engineered "smart" magnetic nanomaterials in Lewis lung carcinoma toxicity studies

Monika A. Cywińska , Ireneusz P. Grudziński , Anita Kośmider , Magdalena Popławska , Michał Bystrzejewski , Andrzej Cieszanowski , Zbigniew Fijałek , Agnieszka Ostrowska

Abstract

Novel self-navigated magnetic nanomaterials are being developed to improve the personalized therapy of cancer through the effective targeted delivery of different biological molecules. Among them, monoclonal antibodies against integrin trans-membrane receptors, a super-family of molecules that mediate both cell-to-cell and cell-to-extracellular matrix signals, have been found to be the innovative drug candidates to be used in both early cancer treatments and cancer diagnosis. In this study, we examined the potential cytotoxicity of the bio-engineered carbon-encapsulated magnetic nanoparticles containing the pre-functionalized carbon surface with monoclonal antibodies recognizing selected integrin receptors. The as-fabricated bio-nanoparticles called “CEMN-MoAbs” were tested for 24 h cytotoxicity studies in murine Lewis lung carcinoma cells (LLC). The 3R-based strategies on CEMN-MoAb nanoparticles (0.0001–100 mcg/ml) were approached using MTT, LDH, Annexin-V/PI, Calcein/PI, JC-1, and cell-cycle analysis. Both TEM and ICP-MS internalization studies were also performed to evidence magnetic nanoparticles bio-distribution in cells. Studies show that CEMN-MoAbs increased mitochondrial and cell membrane cytotoxicity in a dose-dependent manner (MTT/LDH/Calcein/PI). Results also evidence that CEMN-MoAb nanoparticles diminished mitochondrial membrane potentials (JC-1), elevating also some pro-apoptotic events in LLC cells (Annexin-V/PI). Results show that CEMN-MoAb might affect the cell-cycle (cell cycle analysis), and these nanoparticles were widely distributed in cells as determined by TEM/ICP-MS internalization studies. The present results clearly evidence different cellular endpoints for cell membrane, mitochondrial, and nucleus targeted toxicities of monoclonal antibody-navigated carbon-encapsulated magnetic nanoparticles in Lewis lung carcinoma cells.
Author Monika A. Cywińska
Monika A. Cywińska,,
-
, Ireneusz P. Grudziński
Ireneusz P. Grudziński,,
-
, Anita Kośmider
Anita Kośmider,,
-
, Magdalena Popławska (FC / DOC)
Magdalena Popławska,,
- Department Of Organic Chemistry
, Michał Bystrzejewski
Michał Bystrzejewski,,
-
, Andrzej Cieszanowski
Andrzej Cieszanowski,,
-
, Zbigniew Fijałek
Zbigniew Fijałek,,
-
, Agnieszka Ostrowska
Agnieszka Ostrowska,,
-
Journal seriesToxicology Letters, ISSN 0378-4274
Issue year2013
Vol221, Supplement
PagesS93-S93
Publication size in sheets4.65
ASJC Classification3005 Toxicology; 2700 General Medicine
DOIDOI:10.1016/j.toxlet.2013.05.125
URL http://www.sciencedirect.com/science/article/pii/S0378427413003251
Languageen angielski
File
toxicologyletters_2013_221S_S93.pdf 60.85 KB
Score (nominal)35
ScoreMinisterial score = 35.0, 09-09-2019, ArticleFromJournal
Ministerial score (2013-2016) = 35.0, 09-09-2019, ArticleFromJournal
Publication indicators WoS Citations = 0; Scopus SNIP (Source Normalised Impact per Paper): 2013 = 1.199; WoS Impact Factor: 2013 = 3.355 (2) - 2013=3.706 (5)
Citation count*
Cite
Share Share

Get link to the record


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back
Confirmation
Are you sure?